Décines, France, september 2022.
SERF & ARTIQO announce exclusive distribution agreement boosting entry into one of orthopedics’ fastest growing segments.
SERF SASa global orthopedic company -part of the MENIX group – headquartered in Lyon (France) and ARTIQO GmbHa joint reconstruction company with a leading position in the German market based in Lüdinghausen (Germany) are pleased to announce they have reached an exclusive distribution agreement effective immediately. This partnership combines ARTIQO’s unique expertise in calcar-guided short stem, with its market leading A2® along with SERF’s capabilities and outreach as a global European leader in joint reconstruction.
SERF has been enjoying years of double-digit growth and is the undisputed market leader in hip replacement in one the world’s most competitive markets, France. The addition of the A2® range will complement SERF’s hip solutions allowing entry into this fast-growing segment.
Through this agreement, ARTIQO will be able to increase its geographic footprint in selected markets as well as gain access to SERF’s clinically proven solutions such as the NOVAE® Dual Mobility cups or HYPE® stem.
« We are excited to add the A2® to our portfolio, as it will strengthen our market leading position in hip replacement. I have been impressed by ARTIQO’s professionalism, dedication and by its world-class leadership team. The A2® has been designed with the intention to improve patients’ rapid recovery in outpatient surgery while ensuring a strong clinical follow-up, this is perfectly aligned with the high standards we set for ourselves”, said Cyrille Fleury, Chairman & CEO of MENIX Group.
« We could not have thought of a better partner with SERF. Their commitment to improve patients’ lives as well as their market leading hip product solutions will allow us to get to the next level of our development. This is a new chapter in our history, and we are proud to write it with SERF” said Ulrich Bücken, Chairman & CEO of ARTIQO.
About SERF
SERF, founded in 1973, is the inventor of the Dual Mobility acetabular cup concept and is considered as a thought leader in this field. Through its world-famous Novae® Dual Mobility system, SERF sells in 29 countries and enjoys a #1 position in total hip replacements in its home country, France. Since the acquisition of the MadisonTM total knee system from IMPLANET in 2021, SERF now boasts a complete large bones reconstruction portfolio as well as a growing Extremities range.
About ARTIQO
ARTIQO was founded in 2012 by some of the industry’s most seasoned experts. The launch of the calcar-guided A2® short stem in 2016 allowed ARTIQO to be recognized as a leading player on the hip reconstruction market in Germany.
